- Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
Clinical trials
-
Switching from Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention: TAILOR-BLEED-2 study -
SWAP 7 - Investigator
- Francesco Franchi
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
SWAP 9 - Investigator
- Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC who are BCG Na簿ve/Received Incomplete BCG Treatment - Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
The American Lung Association (ALA) Lung Health Cohort (LHC) - Investigator
- Vandana K Seeram
- Ages
- 25 Years - 35 Years
- Sexes
- All
-
Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis - Investigator
- Michael D Schweitzer Barrios
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) - Investigator
- Michael D Schweitzer Barrios
- Ages
- 40 Years - 80 Years
- Sexes
- All
-
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease (20212063) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All